Asthma Drug Market 2023 Forecasts: US, 5EU & Japan Industry Analysis – MarketWatch

Asthma Drug Market 2023 Forecasts: US, 5EU & Japan Industry Analysis
MarketWatch
According to Asthma – 5EU Drug Forecast and Market Analysis to 2023 research report covering the UK, France, Italy, Spain, Germany, the 2013 base-year market sales of asthma products in France were $918m.The relatively slow growth of the German …
Fostair Asthma Market Forecast Analysis in recent reportWhaTech

all 2 news articles »

View full post on asthma – Google News

Overweight children face risk of getting asthma: Research – Daily News & Analysis


Daily News & Analysis

Overweight children face risk of getting asthma: Research
Daily News & Analysis
If your child is overweight, there's one more reason for you to worry. In addition to the usual, risk of obesity and its associated health complications there's a risk of him/her getting asthma too. And if your child is overweight and has asthma too

View full post on asthma – Google News

Overweight kids faces risk of getting asthma- Research – Daily News & Analysis


Daily News & Analysis

Overweight kids faces risk of getting asthma– Research
Daily News & Analysis
If your child is overweight, there's one more reason for you to worry. In addition to the usual, risk of obesity and its associated health complications there's a risk of him/her getting asthma too. And if your child is overweight and has asthma too

View full post on asthma – Google News

Genome-wide association analysis identifies six new loci associated with forced vital capacity.

Related Articles

Genome-wide association analysis identifies six new loci associated with forced vital capacity.

Nat Genet. 2014 Jun 15;

Authors: Loth DW, Artigas MS, Gharib SA, Wain LV, Franceschini N, Koch B, Pottinger TD, Smith AV, Duan Q, Oldmeadow C, Lee MK, Strachan DP, James AL, Huffman JE, Vitart V, Ramasamy A, Wareham NJ, Kaprio J, Wang XQ, Trochet H, Kähönen M, Flexeder C, Albrecht E, Lopez LM, de Jong K, Thyagarajan B, Alves AC, Enroth S, Omenaas E, Joshi PK, Fall T, Viñuela A, Launer LJ, Loehr LR, Fornage M, Li G, Wilk JB, Tang W, Manichaikul A, Lahousse L, Harris TB, North KE, Rudnicka AR, Hui J, Gu X, Lumley T, Wright AF, Hastie ND, Campbell S, Kumar R, Pin I, Scott RA, Pietiläinen KH, Surakka I, Liu Y, Holliday EG, Schulz H, Heinrich J, Davies G, Vonk JM, Wojczynski M, Pouta A, Johansson A, Wild SH, Ingelsson E, Rivadeneira F, Völzke H, Hysi PG, Eiriksdottir G, Morrison AC, Rotter JI, Gao W, Postma DS, White WB, Rich SS, Hofman A, Aspelund T, Couper D, Smith LJ, Psaty BM, Lohman K, Burchard EG, Uitterlinden AG, Garcia M, Joubert BR, McArdle WL, Musk AB, Hansel N, Heckbert SR, Zgaga L, van Meurs JB, Navarro P, Rudan I, Oh YM, Redline S, Jarvis DL, Zhao JH, Rantanen T, O’Connor GT, Ripatti S, Scott RJ, Karrasch S, Grallert H, Gaddis NC, Starr JM, Wijmenga C, Minster RL, Lederer DJ, Pekkanen J, Gyllensten U, Campbell H, Morris AP, Gläser S, Hammond CJ, Burkart KM, Beilby J, Kritchevsky SB, Gudnason V, Hancock DB, Williams OD, Polasek O, Zemunik T, Kolcic I, Petrini MF, Wjst M, Kim WJ, Porteous DJ, Scotland G, Smith BH, Viljanen A, Heliövaara M, Attia JR, Sayers I, Hampel R, Gieger C, Deary IJ, Boezen HM, Newman A, Jarvelin MR, Wilson JF, Lind L, Stricker BH, Teumer A, Spector TD, Melén E, Peters MJ, Lange LA, Barr RG, Bracke KR, Verhamme FM, Sung J, Hiemstra PS, Cassano PA, Sood A, Hayward C, Dupuis J, Hall IP, Brusselle GG, Tobin MD, London SJ

Abstract
Forced vital capacity (FVC), a spirometric measure of pulmonary function, reflects lung volume and is used to diagnose and monitor lung diseases. We performed genome-wide association study meta-analysis of FVC in 52,253 individuals from 26 studies and followed up the top associations in 32,917 additional individuals of European ancestry. We found six new regions associated at genome-wide significance (P < 5 × 10(-8)) with FVC in or near EFEMP1, BMP6, MIR129-2-HSD17B12, PRDM11, WWOX and KCNJ2. Two loci previously associated with spirometric measures (GSTCD and PTCH1) were related to FVC. Newly implicated regions were followed up in samples from African-American, Korean, Chinese and Hispanic individuals. We detected transcripts for all six newly implicated genes in human lung tissue. The new loci may inform mechanisms involved in lung development and the pathogenesis of restrictive lung disease.

PMID: 24929828 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

An estimate of asthma prevalence in Africa: a systematic analysis.

Related Articles

An estimate of asthma prevalence in Africa: a systematic analysis.

Croat Med J. 2013 Dec 28;54(6):519-31

Authors: Adeloye D, Chan KY, Rudan I, Campbell H

Abstract
Aim. To estimate and compare asthma prevalence in Africa in 1990, 2000, and 2010 in order to provide information that will help inform the planning of the public health response to the disease. Methods. We conducted a systematic search of Medline, EMBASE, and Global Health for studies on asthma published between 1990 and 2012. We included cross-sectional population based studies providing numerical estimates on the prevalence of asthma. We calculated weighted mean prevalence and applied an epidemiological model linking age with the prevalence of asthma. The UN population figures for Africa for 1990, 2000, and 2010 were used to estimate the cases of asthma, each for the respective year. Results. Our search returned 790 studies. We retained 45 studies that met our selection criteria. In Africa in 1990, we estimated 34.1 million asthma cases (12.1%; 95% confidence interval [CI] 7.2-16.9) among children <15 years, 64.9 million (11.8%; 95% CI 7.9-15.8) among people aged <45 years, and 74.4 million (11.7%; 95% CI 8.2-15.3) in the total population. In 2000, we estimated 41.3 million cases (12.9%; 95% CI 8.7-17.0) among children <15 years, 82.4 million (12.5%; 95% CI 5.9-19.1) among people aged <45 years, and 94.8 million (12.0%; 95% CI 5.0-18.8) in the total population. This increased to 49.7 million (13.9%; 95% CI 9.6-18.3) among children <15 years, 102.9 million (13.8%; 95% CI 6.2-21.4) among people aged <45 years, and 119.3 million (12.8%; 95% CI 8.2-17.1) in the total population in 2010. There were no significant differences between asthma prevalence in studies which ascertained cases by written and video questionnaires. Crude prevalences of asthma were, however, consistently higher among urban than rural dwellers. Conclusion. Our findings suggest an increasing prevalence of asthma in Africa over the past two decades. Due to the paucity of data, we believe that the true prevalence of asthma may still be under-estimated. There is a need for national governments in Africa to consider the implications of this increasing disease burden and to investigate the relative importance of underlying risk factors such as rising urbanization and population aging in their policy and health planning responses to this challenge.

PMID: 24382846 [PubMed – in process]

View full post on pubmed: asthma

Probiotics during pregnancy and infancy no benefit for asthma: BMJ analysis – NutraIngredients.com

Probiotics during pregnancy and infancy no benefit for asthma: BMJ analysis
NutraIngredients.com
Azad and her team reported that among 3257 infants enrolled in nine trials contributing asthma data, the risk ratio of doctor diagnosed asthma in participants randomised to receive probiotics was 0.99, while the risk ratio of incident wheeze was 0.97.

View full post on asthma – Google News

Asthma Therapeutics Market to 2019 : Global Industry Analysis, Size, Share … – SBWire (press release)

Asthma Therapeutics Market to 2019 : Global Industry Analysis, Size, Share
SBWire (press release)
Albany, NY — (SBWIRE) — 10/09/2013 — Asthma Market to 2019”. The asthma market is forecast to grow marginally over the forecast period across the leading eight developed nations, from $16.6 billion in 2012 to a projected value of $21.6 billion in 2019.

and more »

View full post on asthma – Google News